Asthma medication use during pregnancy, wheeze and estimated exposure to ambient nitrogen dioxide

Asthma affects 8-9% of pregnant women in the USA [1]. Since asthma exacerbations during pregnancy can lead to poor pulmonary function, hypoxia and other adverse health outcomes for the mother, fetus and neonate [2, 3], maintaining good control of asthma during pregnancy is recommended for the health...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The European respiratory journal 2015-02, Vol.45 (2), p.538-540
Hauptverfasser: Gent, Janneane F, Kezik, Julie M, Hill, Melissa E, McKay, Lisa A, Holford, Theodore R, Leaderer, Brian P, Bracken, Michael B
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Asthma affects 8-9% of pregnant women in the USA [1]. Since asthma exacerbations during pregnancy can lead to poor pulmonary function, hypoxia and other adverse health outcomes for the mother, fetus and neonate [2, 3], maintaining good control of asthma during pregnancy is recommended for the health of both mother and baby [4]. Reviews of the safety of asthma medication use during pregnancy suggest no or minimal effects on fetal growth and perinatal complications [4-6]. In spite of this, many pregnant women choose to reduce or stop their asthma medications [7].
ISSN:0903-1936
1399-3003
DOI:10.1183/09031936.00161514